Optimize IAS
  • Home
  • About Us
  • Courses
    • Prelims Test Series
      • LAQSHYA 2026 Prelims Mentorship
    • Mains Mentorship
      • Arjuna 2026 Mains Mentorship
    • Mains Master Notes
  • Portal Login
    • Home
    • About Us
    • Courses
      • Prelims Test Series
        • LAQSHYA 2026 Prelims Mentorship
      • Mains Mentorship
        • Arjuna 2026 Mains Mentorship
      • Mains Master Notes
    • Portal Login

    ADENOVIRUS VACCINE

    • March 14, 2021
    • Posted by: OptimizeIAS Team
    • Category: DPN Topics
    No Comments

     

     

    ADENOVIRUS VACCINE

    Subject: Science & tech

    Context: Unlike the mRNA vaccine platform used by Pfizer and Moderna, where vaccine efficacy reached 94% and 95%, respectively, the vector-based vaccine platform technology used by AstraZeneca and Johnson & Johnson have shown lower efficacy.

    Concept:

    Adenovirus Vector Vaccine :

    • In this vaccine, adenovirus is used as a tool to deliver genes or vaccine antigens to the target host tissue.
    • Adenovirus: Adenoviruses (ADVs) are DNA viruses ranging from 70-90 nanometre in size, which induce many illnesses in humans like cold, respiratory infection etc.
    • Adenoviruses are preferred for vaccines because their DNA is double stranded which makes them genetically more stable and the chances of them changing after injection are lower.
    • Rabies vaccine is an adenovirus vaccine.
    • However, there are drawbacks of adenovirus vector vaccines like pre-existing immunity in humans, inflammatory responses etc.
    • Just as human bodies develop immune responses to most real viral infections, they also develop immunity to adenoviral vectors.
    • Since adenoviral vectors are based on natural viruses that some humans might already have been exposed to, these vaccines might not work for everyone.
    ADENOVIRUS VACCINE Science and tech
    Footer logo
    Copyright © 2015 MasterStudy Theme by Stylemix Themes
        Search